Massachusetts M2I2 program awards $1.85M to Feon Energy, Highland Park Technologies, Terrestrial Bio

The Healey-Driscoll Administration, through the Center for Advanced Manufacturing (CAM) at MassTech, has awarded $1,849,643 in M2I2 capital grants to three Massachusetts hardtech startups. Feon Energy (Woburn) receives $299,643 to build a pilot-scale battery electrolyte manufacturing line and evaluation center, partnering with Northeastern University and Activate Boston. Highland Park Technologies (Somerville) gets $700,000 to establish an in-house production line for insulated cladding systems targeting low-rise residential energy efficiency, working with FORGE on scale-up. Terrestrial Bio (Woburn) receives the largest award at $850,000 to automate and scale its Microneedle Array Patch (MAP) platform for vaccine and therapy delivery, targeting thousands of patches per month with community college internship partnerships. The program expects to create up to 62 jobs across the state.

These awards are structurally significant for the additive manufacturing and advanced manufacturing substrate because they target the bridge between lab-scale innovation and commercial production — precisely the gap that the M2I2 program was designed to close since 2016, having now deployed over $121 million and created more than 1,300 jobs. While none of the three awardees are pure-play AM companies, the Terrestrial Bio MAP platform is a direct bioprinting-adjacent application: microneedle array fabrication increasingly relies on micro-molding and precision deposition techniques that overlap with vat photopolymerization and material extrusion process families. The awards also reinforce the Massachusetts model of university-industry-government co-investment, a pattern that has proven effective in de-risking early-stage manufacturing scale-up for medical-device and energy-storage verticals. The inclusion of community college training pipelines (Bunker Hill, North Shore) addresses a persistent workforce bottleneck in advanced manufacturing scale-up.

From an expert standpoint, the practical signal here is that Massachusetts continues to treat manufacturing scale-up as a public-good investment rather than leaving it entirely to venture capital, which has been retreating from capital-intensive hardtech. For the AM industry specifically, the Terrestrial Bio award is the most relevant: if its MAP platform achieves automated production at thousands-of-units-per-month throughput, it will validate a production model that many bioprinting startups have promised but few have delivered. The key execution risk is whether the $850,000 grant is sufficient to bridge from pilot to meaningful commercial volume, given that automated micro-needle production lines typically require $2-5M in capital equipment alone. Feon Energy's AI-driven electrolyte design platform is a software-service play that could eventually integrate with AM-based electrode or battery component fabrication, but that remains speculative at this stage.